This live webinar series is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with non-small cell lung cancer.

This congress is an educational program that addresses health care professionals' need to be educated on current and emerging evidenced-based scientific data for accurate and timely clinical evaluation of patients with non-small cell lung cancer.

This case report describes the rare occurrence of a T790M resistance mutation found in a central nervous system (CNS) parenchymal metastasis. A concomitant squamous histology transformation in a lung non–T790M-resistant metastasis is also described.

Join Jeffrey Bradley, MD (Radiation Oncology), Ramaswamy Govindan, MD (Medical Oncology), and Peter Humphrey, MD, PhD (Surgical Pathology) as they present their multidisciplinary expertise on a range of cases pertaining to advanced adenocarcinoma.

Managing patients with non-small cell lung cancer (NSCLC) across the disease continuum is a complex task.

Managing patients with non-small cell lung cancer (NSCLC) across the disease continuum is a complex task.

Managing patients with non-small cell lung cancer (NSCLC) across the disease continuum is a complex task.

Managing patients with non-small cell lung cancer (NSCLC) across the disease continuum is a complex task.

Join Jeffrey Bradley, MD (Radiation Oncology), Ramaswamy Govindan, MD (Medical Oncology), and Peter Humphrey, MD, PhD (Surgical Pathology) as they present their multidisciplinary expertise on a range of cases pertaining to advanced adenocarcinoma.

These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung cancer. This topic was a major update for the 2013 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC).